Content about New Drugs & OTCs

June 26, 2012
Abbott's ZonePerfect introduces Perfectly Simple line

Abbott's ZonePerfect brand has introduced a new line of nutrition bars.

June 26, 2012
Pharmavite to debut new product lines under Nature Made brand

The maker of Nature Made has expanded the brand to include a total of 20 offerings across three new product lines.

June 25, 2012
FDA approves Actavis ADHD drug

The Food and Drug Administration has approved a generic drug for attention deficit hyperactivity disorder made by Actavis, the drug maker said Monday.

June 25, 2012
Teva launches generic Symbyax

Teva has launched a generic version of an Eli Lilly drug.

June 25, 2012
Upsher-Smith launches Provella for women

Upsher-Smith Labs has launched a probiotic dietary supplement specifically designed for women to promote digestive, feminine and immune health, the company said.

June 21, 2012
Coca-Cola to bring Core Power to masses

Coca-Cola announced it will distribute a dairy product that is produced and marketed by Fair Oaks Farms Brands, a collective of American family farmers.

June 21, 2012
FDA approves Lyrica for spinal pain

The Food and Drug Administration has approved a new indication for a Pfizer drug.

June 21, 2012
Lansinoh TheraPearl 3-in-1 Breast Therapy packs provide relief for breast-feeding moms

Lansinoh Labs has partnered with TheraPearl to create a first-of-its-kind solution for breast-feeding moms that delivers 360 degrees of relief in a unique cold, warm and hot therapy pack that conforms to the breast.

June 18, 2012
Greenstone launches generic Zyprexa

Greenstone, the generic pharmaceutical subsidiary of Pfizer, has launched olanzapine tablets.

June 18, 2012
HealthNet launches consumer-driven medication management app

HealthNet on Monday released its PillManager mobile application across both Apple and Android platforms. The app allows consumers to track their own medication schedules and interact directly with their doctor or pharmacist for repeat prescriptions.

June 15, 2012
FDA approves MenHibrix

GlaxoSmithKline has received regulatory approval from the Food and Drug Administration for a vaccine designed to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type B.

June 14, 2012
Crown Dynamics introduces patented device to help decrease snoring

Crown Dynamics on Wednesday launched its patented Air Sleep/Snore product line.

June 14, 2012
Kadmon announces launch of 600 mg/day dose pack of Ribasphere RibaPak

Kadmon Pharmaceuticals earlier this month announced that it has launched a new 600 mg/day dose pack of Ribasphere RibaPak (ribavirin, USP), Kadmon's proprietary ribavirin regimen available in a daily, two-pill compliance package for enhanced therapy adherence.

June 12, 2012
Nordic Naturals targets vegetarians with new omega-3 supplement

Nordic Naturals on Tuesday introduced Algae Omega, a solution for vegetarians seeking the health benefits of marine omega-3s. Made from sustainably sourced microalgae and available in both soft gels and liquid, the product offers an algae-based source of beneficial marine omega-3 essential fatty acids without the use of fish.

June 11, 2012
FDA approves Perjeta

Genentech has received regulatory approval for a drug designed to treat breast cancer.

June 7, 2012
Dr. Reddy's launches Parkinson's disease drug

Dr. Reddy's Labs has launched a drug for treating Parkinson's disease, the company said Thursday.

June 7, 2012
Perrigo wins approval for renal failure drug

The Food and Drug Administration has approved a drug for kidney disease made by Perrigo.

June 6, 2012
Ferndale Healthcare launches OTC hemorrhoid therapy

Ferndale Healthcare on Monday announced the launch of RectiCare Anorectal cream, an over-the-counter therapy to help relieve the pain and discomfort associated with hemorrhoids.

June 5, 2012
FDA approves new strength of Lupin antibiotic

The Food and Drug Administration has approved a new dosage of an antibiotic drug made by Lupin Pharmaceuticals, Lupin said Tuesday.

June 1, 2012
Biolife launches WoundSeal first aid product targeting blood-thinner patients

Biolife last month launched WoundSeal, a hemostat product specifically targeting Americans on a regimen of blood thinners.

May 31, 2012
Jarrow Formulas intros omega-3 supplement boasting higher bioavailability

Jarrow Formulas earlier this month launched PhosphOmega, a phospholipid-omega-3 fatty acid complex.

May 31, 2012
Mexican athlete's foot brand making its way across the border to U.S. Hispanic markets

MarcasUSA on Thursday announced the U.S. debut of Conazol, a leading over-the-counter athlete's foot treatment in Mexico.

May 31, 2012
Tris Pharma, Perrigo to bring Delsym generic equivalent to market

Tris Pharma on Thursday announced that the Food and Drug Administration has approved its generic equivalent to Reckitt Benckiser's Delsym, an extended-release oral liquid suspension containing dextromethorphan.

May 30, 2012
FDA approves Ranbaxy acne drug

The Food and Drug Administration has approved a branded acne drug made by Ranbaxy Labs, the drug maker said.

May 29, 2012
Mylan launches generic Lipitor

Mylan on Tuesday announced that its subsidiary has received final approval from the Food and Drug Administration for its abbreviated new drug application for atorvastatin calcium tablets, a generic version of Pfizer's Lipitor.

© 2013 Drug Store News. All Rights Reserved.